Access to clean water is a necessity often taken for granted.

Howard Hughes Medical Institute researchers are reporting the first detailed molecular snapshots of a deadly gastrointestinal virus as it is caught in the grasp of an immune system molecule with the capacity to destroy it.

- The German Federal Ministry for Education and Research (BMBF) awards GENEART a grant of approximately EUR 0.2M - This grant supports advancements in targeted protein design - The objective of the project is the development of a novel vaccine technology - The project is coordinated by the Dutch Company Crossbeta Biosciences Regensburg, July 10, 2008 - GENEART AG, the global leader in gene synthesis and specialist in the field of Synthetic Biology, participates in a joint project to develop a novel vaccine technology by designing a vaccine against the H5N1 avian influenza virus as a test case.